The role of F-18 fluorocholine positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer: correlation with PSA levels

被引：0
|
作者：
Beheshti, M. [1 ]
Zakavi, R. [2 ]
Haim, S. [1 ]
Steinmeir, M. [1 ]
Waldenberger, P.
Wolf, I. [1 ]
Nader, M. [1 ]
Loidl, W.
Langsteger, W. [1 ]
机构：
[1] St Vincents Hosp, PET CT Ctr Linz, Linz, Austria
[2] Mashad Univ Med Sci, Mashhad, Iran
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2011年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S202 / S202
页数：1
相关论文
共 50 条
  • [1] The Role of Choline Positron Emission Tomography/Computed Tomography in the Management of Patients with Prostate-Specific Antigen Progression After Radical Treatment of Prostate Cancer
    Picchio, Maria
    Briganti, Alberto
    Fanti, Stefano
    Heidenreich, Axel
    Krause, Bernd J.
    Messa, Cristina
    Montorsi, Francesco
    Reske, Sven N.
    Thalmann, George N.
    [J]. EUROPEAN UROLOGY, 2011, 59 (01) : 51 - 60
  • [2] Microcosting Study of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Prostate Cancer
    Parkinson, Bonny
    Sharma, Rajan
    Jeet, Varinder
    Song, Rachel
    Hoyle, Martin
    [J]. VALUE IN HEALTH REGIONAL ISSUES, 2022, 32 : 17 - 22
  • [3] Positron Emission Tomography/Computed Tomography with F-18-fluorocholine for Restaging of Prostate Cancer Patients: Meaningful at PSA < 5 ng/ml?
    Martin Heinisch
    Albert Dirisamer
    Wolfgang Loidl
    Franz Stoiber
    Bernhard Gruy
    Silke Haim
    Werner Langsteger
    [J]. Molecular Imaging and Biology, 2006, 8 : 43 - 48
  • [4] 18F-choline positron emission tomography/computed tomography for the detection of prostate cancer relapse: assessment of maximum standardized uptake value correlation with prostate-specific antigen levels
    Siminiak, Natalia
    Wojciechowska, Karolina
    Miechowicz, Izabela
    Cholewinski, Witold
    Ruchala, Marek
    Czepczynski, Rafal
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (12) : 1263 - 1267
  • [5] The Role of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography in the Management of Patients With Prostate Cancer: Implications for Selection of Patients for Radiation Therapy
    Amit, U.
    Goldstein, J. D.
    Davidson, T.
    Hahiashvili, M.
    Goshen, E.
    Oksman, Y.
    Berger, R.
    Saad, A.
    Sadetsky, I.
    Chikman, B.
    Lawrence, Y. R.
    Ben-Haim, S.
    Symon, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S112 - S113
  • [6] Prostate-specific membrane antigen positron emission tomography in the management of recurrent prostate cancer
    Afaq, Asim
    Bomanji, Jamshed
    [J]. BRITISH MEDICAL BULLETIN, 2018, 128 (01) : 37 - 48
  • [7] Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients:: Meaningful at PSA &lt; 5 ng/ml?
    Heinisch, M
    Dirisamer, A
    Loidl, W
    Stoiber, F
    Gruy, B
    Haim, S
    Langsteger, W
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2006, 8 (01) : 43 - 48
  • [8] The Role of Radiolabeled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography for the Evaluation of Renal Cancer
    Evangelista, Laura
    Basso, Umberto
    Maruzzo, Marco
    Novara, Giacomo
    [J]. EUROPEAN UROLOGY FOCUS, 2020, 6 (01): : 146 - 150
  • [9] Case - Prostate-specific antigen bounce: A pitfall in prostate-specific membrane antigen positron emission tomography/computed tomography interpretation
    Pedro, Victor Polins
    Sistani, Golmehr
    Rachinsky, Irina
    Zukotynski, Katherine
    Bauman, Glenn
    Liu, Wei
    [J]. CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2021, 15 (11): : E620 - E621
  • [10] Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Locally Advanced, Recurrent, and Metastatic Prostate Cancer
    Perera, Marlon
    Murphy, Declan
    Lawrentschuk, Nathan
    [J]. JAMA ONCOLOGY, 2018, 4 (05) : 748 - +
12345